![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, November 26, 2014 12:20:50 PM
Take a look at some of the companies that are in phase 3 and it will blow your mind. Moreover, these stocks that are in the triple digits per share with a similar share structure only have 1 drug in the pipeline!
The strategy that I believe that Dr. Koos is trying to accomplish is simply this. Get approval to begin clinical trials for either, get the price per share up and stay there for at least 90 days, and then file to be up listed on a better exchange, most likely NASDAQ. Yes there are requirements other than price per share, but there are ways around that, especially with biotech stocks that are in clinical trials.
A biotech trading on a better exchange with a chance to treat and or cure breast cancer will go through the roof.
I've been away for a while, but rest assured I not only am still on board the RGBP train, but I keep adding when I can. The doubt and whining on here was getting annoying.
I agree with what you quoted, RGBP is most definitely moving forward and beginning to be transparent in their communications and press releases. Stand by folks and enjoy the ride.
Go BMSN!! b
![smile](/images/emoticon01.gif)
All my posts are my opinion based on my own research and due diligence. Trade based on your own, not mine.
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM